TH‐302: A Highly Selective Hypoxia‐Activated Prodrug for Treating PARP Inhibitor–Resistant Cancers

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1155/2024/3809926

TH‐302: A Highly Selective Hypoxia‐Activated Prodrug for Treating PARP Inhibitor–Resistant Cancers

Xiaobo Cheng & Yu Kang et al. · 2024

Links

DOI

Journal

Unknown Journal

Authors

Xiaobo Cheng, Jing Xu, Fanying Meng, Tianyang Qi, Xiaotong Wang, Ranran Chai, Chong Lu, Guanqin Jin, Kewei Zheng, Xing Liu, Yizhi Wang, Xiaohong Cai, Zhaoqiang Lu, Jibing Yu, Meizhen Ruan, Jinwei Fan, Wei Qin, Qunhui Huang, Yanjun Zhang, Anrong Li, Jianxin Duan, Yu Kang